Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,630 total articles
Korsana Biosciences finalized its merger with Cyclerion Therapeutics and completed a $380 million private financing, positioning the company with approximately $475 million in cash to fund operations into 2029. The combined company will begin trading on Nasdaq under ticker KRSA starting September 9, 2026. Korsana’s lead program, KRSA-028, a next-ge…
CAMP4 Therapeutics announced a virtual Analyst Day on September 28, 2026, to present details on CMP-002, a novel antisense oligonucleotide therapeutic designed to treat SYNGAP1-related disorder, a rare genetic condition with no approved disease-modifying therapies. The company plans to initiate a Phase 1/2 clinical trial of CMP-002 in Q4 2026 and w…
Barnes & Noble Education (NYSE: BNED) reported fiscal 2027 first quarter results with a 29% improvement in net income (loss) and 19% improvement in adjusted EBITDA year-over-year. Revenue rose slightly to $290.6 million, driven by growth in the BNC First Day® Complete program, which will reach an estimated 1.43 million students this fall — a 26% in…
ServiceTitan, a leading software platform for contractors and trades, announced its fiscal second quarter 2027 financial results highlighting 21% year-over-year revenue growth to $292.8 million and generating over $50 million in non-GAAP free cash flow. The company emphasized accelerating adoption of its AI-enhanced Agentic Operating System, with o…
ServiceTitan named Rikus Pretorius, former Senior Vice President of Worldwide Sales, as its new Chief Revenue Officer effective from the start of the fiscal fourth quarter. Pretorius succeeds Ross Biestman, who is stepping back from day-to-day operations after nearly a decade as CRO but will remain an advisor through fiscal 2027 to ensure a smooth …
Protara Therapeutics, a clinical-stage biotech company specializing in transformative therapies for cancer and rare diseases, announced management will present at the H.C. Wainwright 28th Annual Global Investment Conference. The presentation will cover their clinical pipeline including TARA-002, focused on non-muscle invasive bladder cancer and lym…
InnovAge Holding Corp. announced its financial results for the fiscal year ended June 30, 2026, highlighting a strong turnaround with nearly $990 million in revenues, a marginal net loss of $0.7 million compared to a $35.3 million loss the prior year, and increased Adjusted EBITDA of $94.6 million. The company also issued optimistic financial guida…
Journey Medical Corporation, a Nasdaq-listed pharmaceutical company specializing in FDA-approved dermatology prescription products, announced CEO Claude Maraoui's participation in two investor conferences in September 2026. The company will present at the Lake Street Capital Markets 10th Annual Best Ideas Growth Conference and the H.C. Wainwright 2…
Intuitive Surgical announced a comprehensive meta-analysis demonstrating that da Vinci robotic-assisted surgery offers statistically significant benefits compared to laparoscopic and open surgeries across 13 common benign conditions. The study analyzed data from over 14 million procedures internationally, highlighting improved perioperative outcome…
Carlsmed, Inc., a Nasdaq-listed medical technology company specializing in AI-enabled personalized spine surgery solutions, has promoted Jeff Bertolini to Chief Operating Officer. Bertolini's history with the company includes leadership roles focused on operational excellence and advanced manufacturing technologies. The management believes his expe…
BridgeBio Oncology Therapeutics reported encouraging clinical data for its KRASG12C inhibitor BBO-8520, showing high response rates in both monotherapy and combination with pembrolizumab in non-small cell lung cancer (NSCLC) patients. The company is prioritizing BBO-8520 combinations in 2L+ KRASG12C inhibitor-experienced NSCLC and advancing BBO-118…
Mission Produce announced its fiscal Q3 2026 financial results, showing 26% revenue growth to $450 million driven by a 38% increase in avocado volume, including contributions from the recent Calavo acquisition. Despite reporting a net loss due to acquisition-related costs, adjusted net income and EBITDA remained strong. The company reaffirmed its f…
Braveheart Bio, a clinical-stage biopharmaceutical company focusing on hypertrophic cardiomyopathy (HCM) treatments, reported successful initiation of the global Phase 3 LIONHEART-HCM trial for BHB-1893 targeting obstructive HCM (oHCM). Following a promising Phase 2 trial demonstrating significant improvements in cardiac biomarkers and function, th…
Keros Therapeutics, a clinical-stage biopharmaceutical company, announced that its Board approved a $5 million share repurchase program funded by a $20 million milestone payment from Takeda Pharmaceuticals after dosing the first patient in the ELRiSE MDS trial. The repurchase authorization allows management to buy back shares depending on market co…
Pyxis Oncology announced a live webcast to present updated clinical data from its Phase 1 study of micvotabart pelidotin (MICVO) as monotherapy in patients with second-line and beyond recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). The presentation will cover efficacy, safety, dosing details, and next clinical development st…
Ascendis Pharma A/S, a biopharmaceutical company focused on innovative TransCon technology, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026. The company highlights its commitment to developing best-in-class therapies addressing unmet medical needs.
CoinShares PLC announced it will release its financial results for the first half of 2026 on September 14, 2026, before market open. The company will hold a live earnings conference call and Q&A session the same day to discuss results, focusing on its digital asset management and institutional platform performance.
Northern Technologies International Corporation (NTIC) has appointed Gautam Ramdas as President and CEO, succeeding G. Patrick Lynch who becomes Chairman of the Board. Brian Haglund is promoted to Chief Operating Officer. These leadership changes are part of NTIC's succession planning designed to capitalize on growth opportunities, especially in co…
Assembly Biosciences has exercised its option to share 40% of U.S. development costs and profits in collaboration with Gilead Sciences for its investigational helicase-primase inhibitor program targeting recurrent genital herpes. The decision follows review of Gilead’s development plan and advances the GS-1179 candidate toward a Phase 2 clinical tr…
Toll Brothers, a leading U.S. luxury home builder, announced the release of a new building at the Iron Creek luxury townhome community in Charlotte, NC. The new four-story townhomes, priced from the low $400,000s, feature rooftop terraces, attached two-car garages, and designer-appointed interiors. Located near Uptown Charlotte and amenities such a…
Quoin Pharmaceuticals announced that the FDA has granted Rare Pediatric Disease designation for its lead asset QRX003 targeting Peeling Skin Syndrome (PSS), a rare and currently untreatable pediatric skin disorder. This is the second such designation for QRX003, also granted for Netherton Syndrome. The designation could qualify Quoin to receive a P…
OPKO Health, a biopharmaceutical and diagnostics company, announced that its President and Vice Chairman Dr. Elias A. Zerhouni and Senior VP and CFO Adam Logal will present at the Wells Fargo 21st Annual Healthcare Conference, including a scheduled fireside chat. The event provides an opportunity to share updates and insights with investors and the…
Tenable Holdings announces integration of Anthropic's advanced AI model Claude Mythos 5 into its Tenable One Exposure Management Platform. This move will enable AI-powered cyber reasoning to better identify hidden attack paths and provide targeted remediation advice, enhancing cybersecurity defenses. The initial product, Tenable One Adversary View,…
Snail, Inc. announced the global launch of "Honeycomb: The World Beyond," a science-fiction survival sandbox game developed by Frozen Way Studio, now available on PC and console platforms including Steam, Epic Games Store, PlayStation 5, and Xbox Series X|S. The game features innovative bioengineering gameplay and integrates advanced Nvidia technol…
Kadant Inc., a leading provider of technologies and engineered systems for sustainable industrial processing, has been named to Newsweek's list of America's Greatest Companies 2026. The recognition reflects Kadant's strong financials, commitment to employee well-being, innovative solutions, and sustainability efforts within the industrial processin…
